Common questions

We can discuss your idea at any point in your research journey. 

In fact, early-stage conversations are welcomed: our experts might be able to give advice to help shape your research into something commercially-viable from the beginning and help keep it protected. 

All conversations are confidential and no obligation. 

That uncertainty is completely normal and we can certainly advise you.

Early support focuses on asking the right questions - who might use your invention, technology or idea, what problem it solves, what’s genuinely different - so you can make a grounded decision without over‑investing time or energy.

Start with a conversation. 

You don’t need a business plan or a polished pitch. The first step is understanding your options and what a sensible next move looks like. Find the Business Manager who knows your area of research here or book a call with them here.

Being cautious is wise, especially when it comes to protecting an idea. The sooner you talk to us, the sooner we can help take the right steps to ensure it is protected.

Our guidance covers intellectual property, timing, and disclosure, so you can talk about your idea with more confidence and avoid accidental missteps.

No! You remain the expert on your research area throughout, but you will acquire new skills and learn about the commercial world. 

UCL Ventures helps to give you enough commercial understanding to make good decisions, and make recommendations for your research and situation, while you stay focused on your area(s) of expertise, be that research, teaching, or clinical work. 

Time pressure is a common concern - but the vast majority of those we work with continue to teach or research. 

Going to market would be an additional pressure on your time but clear stages and guidance from our team of experts help keep it manageable alongside your existing workload. Your Business Manager will be able to help you better understand the commitment needed from you to move forwards effectively.

You can start here. Our role is to help you understand the process, guide you to the pathway that will suit your research and goals, and help you make decisions with confidence. 

Your Business Manager will be able to advise on the processes for each funding pot. They can also share which are - or are not - suitable for you and your research.

Find out who your Business Manager - the commercialisation expert who knows your field of research - is here.

In some cases, yes. If your research could benefit from Proof of Concept funding, to help advance the idea and demonstrate commercial potential, we might be able to support you. 

This can help unlock progress and make your project more attractive to external investors further down the line. Our role is to support your journey from idea to investment readiness, not just connect you with external funding.

Part of our role is to help you understand what different funding options are designed for, what they can and can’t do, and whether they genuinely fit your idea and goals at this stage. 

Speak to the team to learn more.

Yes. In some cases, funding can also support activities that build commercial readiness — such as market exploration, planning, or early validation — not just lab work. There is also dedicated funding available for impact-driven social ventures. 

Funding is only one part of the picture. Support can also include shaping the opportunity, protecting IP, project management, building commercial understanding, and connecting you to the right expertise or partners when appropriate.

See our training and tools available for additional support.

Academic funding is awarded based on research excellence, methodology and potential contribution to knowledge. Funding for early-stage ideas, and later investment into projects, is by contrast, based on commercial potential and the likelihood of market return.

Impact still matters - but grantors and investors will also look closely at your model, scalability and ability to deliver results in a real-world setting. We help you navigate this shift.

Earlier than you might expect.

If you believe your research has commercial potential, it’s worth starting the conversation early. We can help you explore funding options, shape your proposition and avoid common pitfalls - even before you’re actively seeking investment.

Early stages are about sense‑making. This includes slowing things down, asking the right questions, and avoiding premature decisions that could weaken your position later.

It means your idea is clearly defined, appropriately protected, and strong enough to engage external partners or investors — with realistic expectations about what comes next.

Licensing involves granting an existing company the right to use your research, in return for agreed terms, such as fees or royalties. The company takes responsibility for development and market delivery.

Licensing is often suitable when the technology fits well within an established company’s capabilities and product roadmap, such as a therapeutic for a pharmaceutical company that is keen to build out its operations in that disease area.

This route can also work when you prefer a lower‑involvement pathway that doesn’t require building a new organisation, provided your research can be developed by another organisation.

Licensing usually requires less ongoing involvement than a spinout, but each agreement will look different. You may still provide expert input, and some researchers remain close to the project, but you’re not responsible for running or scaling the business.

Not necessarily. For some ideas, licensing can be the most effective way to reach patients, users, or markets at scale through an organisation that already has reach and infrastructure. 

A good licensee fit means finding partners who are technically capable, strategically aligned, and genuinely committed to development — rather than simply acquiring IP without progressing it.

Intellectual property (IP) can include inventions, methods, data, software, designs, and know‑how.

If you have IP, then you can usually take it to market - which means it is important to protect it. 

Not everything is patentable, but many ideas still have protectable value. If your idea is not patentable, our team can also help you understand if there are any automatic rights your work is entitled to that offer some protection, such as copyright or database in rights. 

Early protection helps preserve future options for your idea. Without it, publishing or informal discussions can limit what’s possible later - even if the idea has strong potential. We welcome early, no-obligation discussions to ensure that the right structure is in place for your idea, meaning no one else can copy it.

No, a patent may not always be an appropriate form of protection. 

Conversations with Business Managers focus on understanding what protection is appropriate, when action is needed, along with how to avoid accidental disclosure, such as publishing a paper or giving a presentation, which can jeopardise the protection available to your research.

It’s still worth talking to UCL Ventures to determine where you stand. While some protections may be limited, there may be routes forward depending on what’s been disclosed and how.

Yes — but with guidance. Understanding when and how to have external conversations is a key part of early support, helping you engage without putting the idea at risk. 

Book a confidential discussion here to find out more.

No, protection is about enabling impact. It helps ensure your research can be developed responsibly, attract partners, and reach the people who could benefit from it.

Commercialisation is treated as an extension of excellent research, not a distraction from it. The focus at UCL Ventures is on enabling ideas with real‑world potential to progress responsibly, without undermining academic rigour or integrity.

No. Innovation can take many forms, including licensing, partnerships, Social Ventures / impact‑led routes. The right path depends on the nature of the research and the kind of impact it can create.

Support sits within a broader innovation and entrepreneurial environment at UCL, connecting research excellence with expertise in development, translation, and impact.

This includes some funding, and leveraging expertise.

Yes - we know that ideas can emerge at any stage of a research career. Some of our founders and licensors have taken an idea to market before they have even finished their PhD!

Early conversations are about understanding potential and options, and helping guide you if going to market is something you would like to do.

That’s often the case. Many researchers are motivated by patient benefit, public good, or system change. Commercialisation routes are explored as tools to achieve impact, not ends in themselves.

UCLTF has been involved in activities including technical development, feasibility work, and steps that strengthen the commercial proposition — always focused on enabling informed next decisions.

Please note, TF is not currently making investments. 

The organisation brings experience in technology development and venture creation, and has helped UCL Ventures identify and shape opportunities that have progressed through licensing, spinout creation, partnerships or other impact pathways.

By reducing early uncertainty and risk, the fund has helped position ideas for smoother progression into licensing deals, spinouts, or other impact routes.